Conformis - CFMS Stock Forecast, Price & News

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Conformis in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" CFMS shares.
View CFMS analyst ratings or view top-rated stocks.

2 brokers have issued 1 year price targets for Conformis' stock. Their CFMS share price forecasts range from $1.00 to $8.00. On average, they predict the company's share price to reach $4.50 in the next year. This suggests a possible upside of 82.2% from the stock's current price.
View analysts price targets for CFMS or view top-rated stocks among Wall Street analysts.

Conformis' stock was trading at $3.32 at the beginning of the year. Since then, CFMS stock has decreased by 25.6% and is now trading at $2.47.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 1st 2023.
View our CFMS earnings forecast.

Conformis will be holding an earnings conference call on Wednesday, March 1st at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

Conformis, Inc. (NASDAQ:CFMS) released its quarterly earnings data on Wednesday, November, 3rd. The medical instruments supplier reported ($0.07) EPS for the quarter, hitting the consensus estimate of ($0.07). The medical instruments supplier earned $14.25 million during the quarter, compared to the consensus estimate of $14.08 million. Conformis had a negative trailing twelve-month return on equity of 78.14% and a negative net margin of 104.46%. During the same quarter in the prior year, the firm earned ($0.09) earnings per share.

Conformis updated its fourth quarter 2022 earnings guidance on Wednesday, November, 9th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $13.00 million-$14.00 million, compared to the consensus revenue estimate of $15.99 million.

15 employees have rated Conformis Chief Executive Officer Mark Augusti on Glassdoor.com. Mark Augusti has an approval rating of 55% among the company's employees. This puts Mark Augusti in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Conformis investors own include Advanced Micro Devices (AMD), Martin Midstream Partners (MMLP), Micron Technology (MU), NVIDIA (NVDA), Trevena (TRVN), Cisco Systems (CSCO), Pfizer (PFE), AbbVie (ABBV), Alibaba Group (BABA) and AT&T (T).

(CFMS) raised $135 million in an initial public offering on Wednesday, July 1st 2015. The company issued 9,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan and Deutsche Bank Securities served as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers.

Conformis trades on the NASDAQ under the ticker symbol "CFMS."

Conformis' stock is owned by a number of institutional and retail investors. Top institutional investors include Avidian Wealth Solutions LLC (0.49%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include J Brent Alldredge, Kenneth P Fallon III, Mark A Augusti, Mark A Augusti and Robert S Howe.
View institutional ownership trends.

Shares of CFMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CFMS stock can currently be purchased for approximately $2.47.

Conformis (NASDAQ:CFMS) has a market capitalization of $18.57 million and generates $99.86 million in revenue each year. The medical instruments supplier earns $-2,410,000.00 in net income (profit) each year or ($8.75) on an earnings per share basis.

The company employs 310 workers across the globe.

Conformis' mailing address is 600 TECHNOLOGY PARK DRIVE, BILLERICA MA, 01821. The official website for the company is www.conformis.com. The medical instruments supplier can be reached via phone at (781) 345-9001, via email at ir@conformis.com, or via fax at 781-345-0147.